SEARCH

SEARCH BY CITATION

References

  • Akerman KK. (1996) Analysis of clobazam and its active metabolite norclobazam in plasma and serum using HPLC/DAD. Scand J Clin Lab Invest 56:609614.
  • Allegaert K, Lewi L, Naulaers G, Lagae L. (2006) Levetiracetam pharmacokinetics in neonates at birth. Epilepsia 47:10681069.
  • Alonso Gonzalez AC, Ortega Valin L, Santos Buelga D, Garcia Sanchez ML, Santoz Borbujo J, Monzon Corral L, Dominguez-Gill Hurle A. (1993) Dosage programming of phenobarbital in neonatal seizures. J Clin Pharm Ther 18:267270.
  • Amini H, Javan M, Ahmadiani A. (2006) Development and validation of a sensitive assay of valproic acid in human plasma by high-performance liquid chromatography without prior derivatization. J Chromatogr B Analyt Technol Biomed Life Sci 830:368371.
  • Andre M, Boutroy MJ, Dubruc C, Thenot JP, Bianchetti G, Sola L, Vet P, Morselli PL. (1986) Clonazepam pharmacokinetics and therapeutic efficacy in neonatal seizures. Eur J Clin Pharmacol 30:585589.
  • Armijo JA, Cuadrado A, Bravo J, Arteaga R. (1997) Vigabatrin serum concentration to dosage ratio: influence of age and associated antiepileptic drugs. Ther Drug Monit 19:491498.
  • Armijo JA, Perna MA, Adin J, Vega-Gil N. (2004) Association between patient age and gabapentin serum concentration-to-dose ratio: a preliminary multivariate analysis. Ther Drug Monit 26:633637.
  • Arroyo S, Anhut H, Kugler AR, Lee CM, Knapp LE, Garofalo EA, Messmer S, Pregabalin 1009–011 International Study Group. (2004) Pregabalin add-on treatment: a randomomised, double-blind, placebo-controlled, dose-response study in adults with partial seizures. Epilepsia 45:2027.
  • Asconape JJ, Penry JK. (1982) Use of antiepileptic drugs in the presence of liver and kidney diseases: a review. Epilepsia 23(Suppl. 1):S65S79.
  • Aucamp AK. (1982) Aspects of the pharmacokinetics and pharmacodynamics of benzodiazepines with particular reference to clobazam. Drug Dev Res Suppl 1:117126.
  • Aylett SE, Cross JH, Berry D. (2005) Clobazam toxicity in a child with epilepsy related to idiosyncratic metabolism. Dev Med Child Neurol 48:612615.
  • Bajpai M, Roskos LK, Shen DD, Levy RH. (1996) Roles of cytochrome P4502C9 and cytochrome P4502C19 in the stereoselective metabolism of phenytoin to its major metabolite. Drug Metab Dispos 24:140143.
  • Barre J, Didey F, Delion F, Tillement JP. (1988) Problems in therapeutic drug monitoring: free drug concentration monitoring. Ther Drug Monit 10:133143.
  • Bartoli A, Guerrini R, Belmonte A, Alessandri MG, Gatti G, Perucca E. (1997) The influence of dosage, age, and comedication on steady state plasma lamotrigine concentrations in epileptic children: a prospective study with preliminary assessment of correlations with clinical response. Ther Drug Monit 19:252260.
  • Battino D, Avanzini G, Bossi L, Croci C, Gomeni C, Moise A. (1983) Plasma levels of primidone and its metabolite phenobarbital: effect of age and associated therapy. Ther Drug Monit 5:7379.
  • Battino D, Binelli S, Bossi L, Como ML, Croci D, Cusi C, Avanzini G. (1984) Changes in primidone/phenobarbitone ratio during pregnancy and the puerperium. Clin Pharmacokinet 9:252260.
  • Battino D, Estienne M, Avanzini G. (1995a) Clinical pharmacokinetics of antiepileptic drugs in pediatric patients. Part I: Phenobarbital, primidone, valproic acid, ethosuximide and methsuximide. Clin Pharmacokinet 29:257286.
  • Battino D, Estienne M, Avanzini G. (1995b) Clinical pharmacokinetics of antiepileptic drugs in pediatric patients. Part II. Phenytoin, carbamazepine, sulthiame, lamotrigine, vigabatrin, oxcarbazepine and felbamate. Clin Pharmacokinet 29:341369.
  • Battino D, Croci D, Granata T, Manoli D, Messina S, Perucca E. (2001) Single-dose pharmacokinetics of lamotrigine in children: influence of age and antiepileptic comedication. Ther Drug Monit 23:217222.
  • Battino D, Croci D, Rossini A, Messina S, Mamoli D, Perucca E. (2003) Serum carbamazepine concentrations in elderly patients: a case-matched pharmacokinetic evaluation based on therapeutic drug monitoring data. Epilepsia 44:923929.
  • Battino D, Croci D, Mamoli D, Messina S, Perucca E. (2004) Influence of aging on serum phenytoin concentrations: a pharmacokinetic analysis based on therapeutic drug monitoring data. Epilepsy Res 59:155165.
  • Bauer LA. (1982) Interference of oral phenytoin absorption by continuous nasogastric feedings. Neurology 32:570572.
  • Bauer LA, Blouin RA. (1982) Age and phenytoin kinetics in adult epileptics. Clin Pharmacol Ther 31:301304.
  • Bauer LA, Harris C, Wilensky A, Raisys V, Levy R. (1982) Ethosuximide kinetics: possible interaction with valproic acid. Clin Pharmacol Ther 31:741745.
  • Beardsley RS, Freeman JM, Appel FA. (1983) Anticonvulsant serum levels are useful only if the physician appropriately uses them: an assessment of the impact of providing serum level data to physicians. Epilepsia 24:330335.
  • Behnke CE, Reddy MN. (1997) Determination of felbamate concentration in pediatric samples by high-performance liquid chromatography. Ther Drug Monit 19:301306.
  • Ben-Menachem E. (2004) Pregabalin pharmacology and its relevance to clinical practice. Epilepsia 45(Suppl. 6):1318.
  • Berent S, Sackellares JC, Giordani B, Wagner JG, Donofrio PD, Abou-Khalil B. (1987) Zonisamide (CI-912) and cognition: results from preliminary study. Epilepsia 28:6167.
  • Berlin A, Dahlstrom H. (1975) Pharmacokinetics of the anticonvulsant drug clonazepam evaluated from single oral and intravenous doses and repeated administration. Eur J Clin Pharmacol 9:155159.
  • Bernus I, Dickinson RG, Hooper WD, Eadie MJ. (1994a) Inhibition of phenobarbitone N-glucosidation by valproate. Br J Clin Pharmacol 38:411416.
  • Bernus I, Dickinson RG, Hooper WD, Eadie MJ. (1994b). Early stage autoinduction of carbamazepine metabolism in humans. Eur J Clin Pharmacol 47:355360.
  • Bernus I, Dickinson RG, Hooper WD, Eadie MJ. (1997) Anticonvulsant therapy in aged patients. Clinical pharmacokinetic considerations. Drugs Aging 10:278269.
  • Berry DJ. (1990) Determination of zonisamide (3-suphamoylmethyl-1,2-benzisoxazole) in plasma at therapeutic concentrations by high-performance liquid chromatography. J Chromatogr 534:173181.
  • Berry DJ, Patsalos PN. (2000) Comparison of topiramate concentrations in plasma and serum by fluorescence polarization immunoassay. Ther Drug Monit 22:460464.
  • Berry DJ, Beran RG, Plunkeft MJ, Clarke LA, Hung WT. (2003) The absorption of gabapentin following high dose escalation. Seizure 12:2836.
  • Berry D, Millinigton C. (2005) Analysis of pregabalin at therapeutic concentrations in human plasma/serum by reversed-phased HPLC. Ther Drug Monit 27:451456.
  • Bertilsson L, Hojer B, Tybring G, Osterloh J, Rane A. (1980) Autoinduction of carbamazepine metabolism in children examined by a stable isotope technique. Clin Pharmacol Ther 127:8388.
  • Bertilsson L, Tomson T, Tybring G. (1986) Pharmacokinetics: time-dependent changes–autoinduction of carbamazepine epoxidation. J Clin Pharmacol 26:459462.
  • Besag FM, Berry DJ, Pool F. (1998) Carbamazepine toxicity with lamotrigine: pharmacokinetic or pharmacodynamic interaction. Epilepsia 39:183187.
  • Besag FM, Berry DJ, Pool F. (2000) Methsuximide lowers lamotrigine blood levels: A pharmacokineric antiepileptic drug interaction. Epilepsia 41:624627.
  • Besag FM, Berry DJ, Vasey M. (2001) Methsuximide reduces valproic acid serum levels. Ther Drug Monit 23:694697.
  • Bhatti, MM, Hanson GD, Schultz L. (1998) Simultaneous determination of phenytoin, carbamazepine, and 10, 11-carbamazepine epoxide in human serum by high-performance liquid chromatography with ultraviolet detection. J Pharm Biomed Anal 16:12331240.
  • Birnbaum A, Hardie NA, Leppik IE, Conway JM, Bowers SE, Lackner T, Graves NM. (2003) Variability of total phenytoin serum concentrations within elderly nursing home residents. Neurology 60:555559.
  • Biton V. (2006) Pharmacokinetics, toxicology and safety of lamotrigine in epilepsy. Expert Opin Drug Metab Toxicol 2:10091018.
  • Bittigau P, Sifringer M, Ikonomidou C. (2003) Antiepileptic drugs and apoptosis in the developing brain. Ann N Y Acad Sci 993:103114.
  • Bloedow DC, Hansbrough JF, Hardin T, Simons M. (1986) Postburn serum drug binding and serum protein concentrations. J Clin Pharm 26:147151.
  • Bockbrader HN, Hunt T, Strand J, Posver El, Sedman A. (2000) Pregabalin pharmacokinetics and safety in healthy volunteers: results from two phase 1 studies. Neurology 11(Suppl. 3):412.
  • Boggs JG. (2001) Elderly patients with systemic disease. Epilepsia 42(Suppl. 8):1823.
  • Booker HE, Hosokowa K, Burdette RR, Darcey B. (1970) A clinical study of serum primidone levels. Epilepsia 11:395402.
  • Borusiak P, Korn-Merker E, Holert N. (1998) Oxcarbazepine in treatment of childhood epilepsy: a survey of 46 children and adolescents. J Epilepsy 11:355360.
  • Bourgeois BFD, Dodson WE, Ferrendelli JA. (1982) Interactions between primidone, carbamazepine, and nicotimamide. Neurology 32:11221126.
  • Bourgeois BFD, Dodson WE. (1983) Phenytoin elimination in newborns. Neurology 33:173178.
  • Bourgeois BFD. (1988) Pharmacologic interactions between valproate and other drugs. Am J Med 84:2833.
  • Bowdle AT, Patel IH, Levy RH, Wilensky AJ. (1980) Valproic acid dosage and plasma protein binding and clearance. Clin Pharmacol Ther 28:486492.
  • Britzi M, Perucca E, Soback S, Levy RH, Fattore C, Crema F, Gatti G, Doose DR, Maryanoff BE, Bialer M. (2005) Pharmacokinetic and metabolic investigation of topiramate disposition in healthy subjects in the absence and in the presence of enzyme induction by carbamazepine. Epilepsia 46:378384.
  • Brodie MJ, Richens A, Yuen AW. (1995) Double-blind comparison of lamotrigine and carbamazepine in newly diagnosed epilepsy. UK Lamotrigine/Carbamazepine Monotherapy Trial Group. Lancet 345:476479.
  • Brodie MJ, Overstall PW, Giorgi L. (1999) Multicentre, double-blind, randomized comparison between lamotrigine and carbamazepine in elderly patients with newly diagnosed epilepsy. The UK Lamotrigine Elderly Study Group. Epilepsy Res 37:8187.
  • Browne TR, Dreifuss FE, Dyken PR, Goode DJ, Penry JK, Porter RJ, White BG, White PT. (1975) Ethosuximide in the treatment of absence (petit mal) seizures. Neurology 25:515524.
  • Browne TR, Evans JE, Szabo GK, Evans BA, Greenblatt DJ. (1985) Studies with stable isotopes II: Phenobarbital pharmacokinetics during monotherapy. J Clin Pharmacol 25:5158.
  • Buchanan R, Fernandez L, Kinkel A. (1969) Absorption and elimination of ethosuximide in children. J Clin Pharmacol 9:693698.
  • Buchanan R, Kinkel A, Smith T. (1973) The absorption and excretion of ethosuximide. Int J Clin Pharmacol 7:213218.
  • Buchanan RA, Bockbrader HN, Chang T, Sedman AJ. (1996) Single- and multiple-dose pharmacokinetics of zonisamide. Epilepsia 37(Suppl. 5):172.
  • Buchthal F, Svensmark O. (1960) Aspects of the pharmacology of phenytoin (dilantin) and phenobarbital relevant to their dosage in the treatment of epilepsy. Epilepsia 1:373384.
  • Buchthal F, Svensmark O, Schiller PJ. (1960) Clinical and electroencephalographic correlations with serum levels of diphenylhydantoin. Arch Neurol 2:624630.
  • Busch JA, Strand JC, Posvar EL, Bockbrader HN, Radulovic LL. (1998) Pregabalin (CI-1008) single-dose pharmacokinetics and safety/tolerance in healthy subjects after oral administration of pregabalin solution or capsule doses. Epilepsia 39(Suppl. 6):58.
  • Carter BL, Garnett WR, Pellock JM, Stratton MA, Howell JR. (1981) Effect of antacids on phenytoin bioavailability. Ther Drug Monit 3:333340.
  • Casas, MN, Blanco CC, Carretero AS, Gutierrez AF. (2004) Simple and rapid micellar electrokinetic capillary chromatographic method for simultaneous determination of four antiepileptics in human serum. Biomed Chromatogr 18:608612.
  • Cazali N, Tran A, Treluyer JM, Rey E, D'Athis P, Vincent J, Pons G. (2003) Inhibitory effect of stiripentol on carbamazepine and saquinavir metabolism in human. Br J Clin Pharmacol 56:526536.
  • Chan KK, Sawchuk RJ, Thompson TA, Redalieu E, Wagner WE, LeSher AR, Weeks BJ, Hall NR, Gerardin A. (1985) Bioequivalence of carbamazepine chewable and conventional tablets: Single-dose and steady-state studies. J Pharm Sci 74:866870.
  • Chen S, Carvey P. (2001) Validation of liquid-liquid extraction followed by flow-injection negative ion electrospray mass spectrometry assay to topiramate in human plasma. Rapid Commun Mass Spectrom 15:159163.
  • Chiba K, Ishizaki T, Miura H, Minagawa K. (1980) Michaelis-Menten pharmacokinetics of diphenylhydantoin and application in the pediatric age patient. J Pediatr 96:479484.
  • Chiron C, Marchand MC, Tran A, D'Athis P, Vincent J, Dulac O, Pons G. (2000) Stiripentol in severe myoclonic epilepsy in infancy: a randomized placebo-controlled syndrome-dedicated trial. STICLO study group. Lancet 356:16381642.
  • Chollet DF, Castella E, Goumaz L, Anderegg G. (1999) Gas chromatography-mass spectrometry assay method for the therapeutic drug monitoring of the antiepileptic drug tiagabine. J Pharm Biomed Anal 21:641646.
  • Chollet DF, Goumaz L, Juliano C, Anderegg G. (2000) Fast isocratic high-performance liquid chromatographic assay method for the simultaneous determination of gabapentin and vigabatrin in human serum. J Chromatogr B Biomed Sci Appl 746:311314.
  • Christensen J, Højskov CS, Poulsen JH. (2002) Liquid chromatography tandem mass spectrometry assay for topiramate in plasma and cerebrospinal fluid: validation and comparison with fluorescence-polarization immunoassay. Ther Drug Monit 24:658664.
  • Christensen J, Andreasen F, Poulsen JH, Dam M. (2003) Randomized, concentration-controlled trial of topiramate in refractory focal epilepsy. Neurology 61:12101218.
  • Christensen J, Sabers A, Sidenius P. (2006) Oxcarbazepine concentrations during pregnancy: a retrospective study in patients with epilepsy. Neurology 24:14971499.
  • Christensen J, Petrenaite V, Atterman J, Sidenius P, Ohman I, Tomson T, Sabers A. (2007) Oral contraceptives induce lamotrigine metabolism: Evidence from a double-blind, placebo-controlled trial. Epilepsia 48:484489.
  • Cleton A, De Greef HJ, Edelbroek PM, Voskuyl RA, Danhof M. (1999) Stereoselective central nervous effects of the R- and S-isomers of the uptake blocker N-(4, 4-di-(3-methylthien-2-yl)but-3-enyl) nipecotic acid in the rat. Br J Pharmacol 128:16511658.
  • Cloyd JC, Miller KW, Leppik IE. (1981) Primidone kinetics: Effects of concurrent drugs and duration of therapy. Clin Pharmacol Ther 29:402407.
  • Cloyd JC, Fischer JH, Kriel RL, Kraus DM. (1993) Valproic acid pharmacokinetics in children. IV. Effects of age and antiepileptic drugs on protein binding and intrinsic clearance. Clin Pharmacol Ther 53:2229.
  • Cloyd JC, Lackner TE, Leppik IE. (1994) Antiepileptics in the elderly. Pharmacoepidemiology and pharmacokinetics. Arch Famacol Med 3:589598.
  • Cloyd J, Birnbaum A, Musib L, Leppik I. (2001) Clinical pharmacology of phenytoin in the elderly. Epilepsia 42(Suppl 2):1112.
  • Commission on Antiepileptic Drugs. (1993) Guidelines for therapeutic monitoring on antiepileptic drugs. Epilepsia 34:585587.
  • Contin M, Riva R, Albani F, Baruzzi AA. (1999) Effect of felbamate on clobazam and its metabolite kinetics in patients with epilepsy. Ther Drug Monit 21:604608.
  • Contin M, Riva R, Albani F, Baruzzi A. (2001) Simple and rapid liquid chromatographic-turbo ion spray mass spectrophotometric determination of topiramate in human plasma. J Chromatogr B Biomed Sci Appl 761:133137.
  • Contin M, Sangiorgi S, Riva R, Parmeggiani A, Albani F, Baruzzi A. (2002) Evidence of polymorphic CYP2C19 involvement in the human metabolism of N-desmethylclobazam. Ther Drug Monit 24:737741.
  • Contin M, Albani F, Riva R, Baruzzi A. (2004) Levetiracetam therapeutic monitoring in patients with epilepsy: effect of concomitant antiepileptic drugs. Ther Drug Monit 26;375379.
  • Contin M, Balboni M, Callegati E, Candela C, Albani F, Riva R, Baruzzi A. (2005) Simultaneous liquid chromatographic determination of lamotrigine, oxcarbazepine monohydroxy derivative and felbamate in plasma of patients with epilepsy. J Chromatogr B Analyt Technol Biomed Life Sci 828:113117.
  • Corrigan BW, Poole WF, Posvar EL, Strand JC, Alvey CW, Radulovic LL. (2001) Metabolic disposition of pregabalin in healthy volunteers. Clin Pharmacol Ther 69:P18.
  • Cramer JA, Mattson RH, Prevey ML, Scheyer RD, Ouellette VL. (1989) How often is medication taken as prescribed? A novel assessment technique. J Am Med Assoc 261:32733277.
  • Croci D, Salmaggi A, De Grazia U, Bernardi G. (2001) New high-performance liquid chromatographic method for plasma/serum analysis of lamotrigine. Ther Drug Monit 23:665268.
  • Dasgupta A, Timmerman TG. (1996) In vitro displacement of phenytoin from protein binding by nonsteroidal antiinflammatory drugs tolmetin, ibuprofen, and naproxen in normal and uremic sera. Ther Drug Monit 18:9799.
  • De Boer AG, Rost-Kaiser J, Bracht H, Breimer DD. (1978) Assay of underivatised nitrazepam and clonazepam in plasma by capillary gas chromatography applied to pharmacokinetics and bioavailability studies in humans. J Chromatogr 145:105114.
  • De Carvalho D, Lanchote VL. (1991) Measurement of plasma clonazepam for therapeutic control: A comparison of chromatographic methods. Ther Drug Monit 13:5563.
  • De Haan GJ, Edelbroek P, Segers J, Engelsman M, Lindhout D, Devile-Notschaele M, Augustijn P. (2004) Gestation-induced changes in lamotrigine pharmacokinetics: a monotherapy study. Neurology 63:571573.
  • Depot M, Powell JR, Messenheimer JA, Cloutier G, Dalton MJ. (1990) Kinetic effects of multiple oral doses of acetaminophen on a single oral dose of lamotrigine. Clin Pharmacol Ther 48:346355.
  • Dhar AK, Kutt H. (1981) Improved gas chromatographic procedure for the determination of clonazepam levels in plasma using a nitrogen-sensitive detector. J Chromatogr B Biomed Appl 222:203211.
  • Divoll M, Greenblatt D, Ciraulo DA, Puri SK, Ho I, Shader RI. (1982) Clobazam kinetics: intrasubject variability and effect of food on absorption. J Clin Pharmacol 22:6973.
  • Dodson WE, Bourgeois BFD. (1994) Pharmacology and therapeutic aspects of antiepileptic drugs in pediatrics. J Child Neurol 9(Suppl 2):17.
  • Doose DR, Walker SA, Gisclon LG, Nayak RK. (1996) Single-dose pharmacokinetics and affect of food on the bioavailability of topiramate, a novel antiepileptic drug. J Clin Pharmacol 36:884891.
  • Doose DR, Streeter AJ. (2002) Topiramate: Chemistry, biotransformation, and pharmacokinetics. In LevyRH, MattsonRH, MeldrumBS, PeruccaE. (Eds) Antiepileptic Drugs 5th ed, Lippincott Williams & Wilkins, Philadelphia , pp. 727734.
  • Drefuss FE, Penry JK, Rose SW, Kupferberg HJ, Dyken P, Sato S. (1975) Serum clonazepam concentrations in children with absence seizures. Neurology 25:255258.
  • Drouet-Coassolo C, Aubert C, Coassolo P, Cano JP. (1989) Capillary gas chromatographic-mass spectrometric method for the identification and quantification of some benzodiazepines and their unconjugated metabolites in plasma. J Chromatogr 487:295311.
  • Durham SL, Hoke JF, Chen TM. (1993) Pharmacokinetics and metabolism of vigabatrin following a single oral dose of [14C] vigabatrin in healthy male volunteers. Drug Metab Dispos 21:480484.
  • Dworkin RH, Corbin AE, Young Jr JP, Sharma U, LaMareaux L, Bockbrader H, Garofalo EA, Poole RM. (2003) Pregabalin for the treatment of postherpetic neuralgia: a randomized, placebo-controlled trial. Neurology 60:12741283.
  • Eadie MJ, Tyrer JH, Smith GA, McKauge L. (1977) Pharmacokinetics of drugs used for petit mal 'absence' epilepsy. Clin Exp Neurol 14:172183.
  • Eadie MJ. (1997) Indications for plasma drug monitoring in patients with epilepsy. Implications for reducing costs. Pharmacoeconomics 11:343349.
  • Ebert U, Thong NQ, Oertel R, Kirch W. (2000) Effects of rifampicin and cimetidine on pharmacokinetics and pharmacodynamics of lamotrigine in healthy subjects. Eur J Clin Pharmacol 56:299304.
  • Elyas AA, Goldberg VD, Patsalos PN. (1990) Simple and rapid microanalytical high performance liquid chromatography technique for the assay of oxcarbazepine and its primary active metabolite 10-hydroxy carbazepine. J Chromatogr 528:473479.
  • Easterling DE, Zakszewski T, Moyer MD, Margul BL, Marriott TB, Nayak RK. (1988) Plasma pharmacokinetics of topiramate, a new anticonvulsant in humans. Epilepsia 29:662.
  • Faught E, Sachdeo RC, Remler MP, Chayasirisobhon S, Iragui-Madoz VJ, Ramsay RE, Sutula TP, Kanner A, Harner RN, Kuzniecky R, Kramer LD, Kamin M, Rosenberg A. (1993) Felbamate monotherapy for partial-onset seizures: An active-control trial. Neurology 43:688692.
  • Fay MA, Sheth RD, Gidal BE. (2005) Oral absorption kinetics of levetiracetam: the effect of mixing with food or enteral nutrition formulas. Clin Ther 27:594598.
  • Feldman RG, Pippenger CE. (1976) The relation of anticonvulsant drug levels to complete seizure control. J Clin Pharmacol 16:5159.
  • Fischer JH, Lockman LA, Zaske D, Kriel R. (1981) Phenobarbital maintenance dose requirements in treating neonatal seizures. Neurology 31:10421044.
  • Fischer JH, Barr AN, Paloucek FP, Dorociak JV, Spunt AL. (1988) Effect of food on the serum concentration profile of enetric-coated valproic acid. Neurology 38:13191322.
  • Fitton A, Goa KL. (1995) Lamotrigine. An update of its pharmacology and therapeutic use in epilepsy. Drugs 50:691713.
  • Flesch G, Francotte E, Hell F, Degen PH. (1992) Determination of the R-(−) and S-(+) enantiomers of the monohydroxylated metabolite of oxcarbazepine in human plasma by enantioselective high-performance liquid chromatography. J Chromatogr 581:147151.
  • Forssblad E, Eriksson AS, Beck O. (1996) Liquid chromatographic determination lamotrigine in pediatric samples. J Pharm Biomed Anal 14:755758.
  • Fraser DG, Ludden TM, Evens RP, Sutherland EW. (1980) Displacement of phenytoin from plasma binding sites by salicylate. Clin Pharmacol Ther 27:165169.
  • Fraser AD, MacNeil W, Isner AF, Camfield PR. (1995) Lamotrigine analysis in serum by high-performance liquid chromatography. Ther Drug Monit 17:174178.
  • Friis ML, Kristensen O, Boas J, Dalky M, Deth SH, Gram L, Mikkelsen M, Pedersen B, Sabers A, Worm-Patersen J. (1993) Therapeutic experiences with 947 epileptic out-patients in oxcarbazepine treatment. Acta Neurol Scand 87:224227.
  • Frisk-Holmberg M, Kerth P, Meyer P. (1989) Effect of food on the absorption of vigabatrin. Br J Clin Pharmacol 27:23S25S.
  • Fröscher W, Eichelbaum M, Gugler R, Hildenbrand G, Penin H. (1981) A prosepctive randomized trial on the effect of monitoring plasma anticonvulsant levels in epilepsy. J Neurol 224:193201.
  • Fröscher W, Keller F, Vogt H, Krämer G. (2002) Prospective study on concentrations-efficacy and concentration-toxicity correlations with lamotrigine serum levels. Epileptic Disord 4:4956.
  • Galimberti CA, Mazzucchelli I, Arbasini C, Canevini MP, Fattore C, Perucca E. (2006) Increased apparent oral clearance of valproic acid during intake of combined contraceptive steroids in women with epilepsy. Epilepsia 47:15691572.
  • Gallagher BB, Baumel IP, Mattson RH. (1972) Metabolic disposition of primidone and its metabolites in epileptic subjects after single and repeated administration. Neurology 22:11861192.
  • Gannaway DJ, Mawer GE. (1981) Serum phenytoin concentration and clinical response in patients with epilepsy. Br J Clin Pharmacol 12:833839.
  • Gardner-Thorpe C, Meinardi H, Pippenger CE. (1977) Antiepileptic drug monitoring. Pitman Medical, Tunbridge Wells .
  • Garrettson LK, Dayton PG. (1970) Disappearance of phenobarbital and diphenylhydantoin from serum of children. Clin Pharmacol Ther 11:674679.
  • Gatti G, Bartoli A, Marchiselli R, Michelucci R, Tassinari CA, Pisani F, Zaccara G, Timmings P, Richens A, Perucca E. (1993) Vigabatrin-induced decrease in serum phenytoin concentration does not involve a change in phenytoin bioavailability. Br J Clin Pharmacol 36:603606.
  • Gatti G, Ferrari AR, Guerrini R, Bonanni P, Bonomi I, Perucca E. (2003) Plasma gabapentin concentrations in children with epilepsy: Influence of age, relationship with dosage, and preliminary observations on correlation with clinical response. The Drug Monit 25:5460.
  • George S, Wood AJ, Braithwaite RA. (1995) Routine therapeutic monitoring of lamotrigine in epileptic patients using a simple and rapid high performance liquid chromatographic technique. Ann Clin Biochem 32:584588.
  • George S, Gill L, Braithwaite RA. (2000) Simple high-performance liquid chromatographic method to monitor vigabatrin, and preliminary review of concentrations determined in epileptic patients. Ann Clin Biochem 37:338342.
  • Giaccone M, Bartoli A, Gatti G, Marchiselli R, Pisani F, Latella MA, Perucca E. (1996) Effect of enzyme-inducing anticonvulsants on ethosuximide pharmacokinetics in epileptic patients. Br J Clin Pharmacol 41:575579.
  • Gidal BE, Spencer NW, Maly MM, Pitlerle ME. (1996) Evaluation of carbamazepine and carbamazepine-epoxide protein binding in patients undergoing epilepsy surgery. Epilepsia 37:381385.
  • Gidal BE, Radulovic LL, Kruger S, Rutecki P, Pitterle M, Bockbrader HN. (2000) Inter- and intra-subject variability in gabapentin absorption and absolute bioavailability. Epilepsy Res 40:123127.
  • Giraud C, Treluyer JM, Rey E, Chiron C, Vincent J, Pons G, Tran A. (2006) In vitro and in vivo inhibitory effect of stiripentol on clobazam metabolism. Drug Metab Dispos 34:608611.
  • Glauser TA, Miles MV, Tang P, Clark P, McGee K, Doose DR. (1999) Topiramate pharmacokinetics in infants. Epilepsia 40:788791.
  • Glauser TA, Pippenger CE. (2000) Controversies in blood-level monitoring: Re-examining its role in the treatment of epilepsy. Epilepsia 41(Suppl. 8):S6S15.
  • Glauser TA. (2002) Advancing the medical management of epilepsy: disease modification and pharmacogenetics. J Child Neurol 17(Suppl. 1):S85S93.
  • Glauser TA, Mitchell WG, Weinstock A, Bebin M, Chen D, Coupez R, Stockis A, Lu Z. (2007) Pharmacokinetics of levetiracetam in infants and young children with epilepsy. Epilepsia 48:11171122.
  • Glazko AJ, Chang T, Baukema J, Dill WA, Goulet JR, Buchanan RA. (1969) Metabolic disposition of diphenylhydantoin in normal human subjects following intravenous administration. Clin Pharmacol Ther 10:498504.
  • Glue P, Banfield CR, Perhach JL, Mather GG, Racha JK, Levy RH. (1997) Pharmacokinetic interactions with felbamate. In vitro-in vivo correlation. Clin Pharmacokinet 33:214224.
  • Gram L, Flachs H, Wurtz-Jorgensen A, Parnas J, Andersen B. (1979) Sodium valproate, serum level and clinical effect in epilepsy: a controlled study. Epilepsia 20:303311.
  • Gram L, Lyon BB, Dam M. (1983) Gamma-vinyl-GABA: A single blind trial in patients with epilepsy. Acta Neurol Scand 68:3439.
  • Graves NM, Kriel RL, Jones-Saete C, Cloyd JC. (1985) Relative bioavailability of rectally administered carbamazepine suspension in humans. Epilepsia 26:429433.
  • Graves NM, Brundage RC, Wen Y, Cascino G, So E, Ahman P, Rarick J, Krause S, Leppik IE. (1998) Population pharmacokinetics of carbamazepine in adults with epilepsy. Pharmacotherapy 18:273281.
  • Greenblatt DJ. (1980) Electron-capture GLC determination of clobazam and desmethylclobazam in plasma. J Pharm Sci 69:13511352.
  • Greenblatt DJ, Divoll M, Puri SK, Ho I, Zinny MA, Shader RI. (1981) Clobazam kinetics in the elderly. Br J Clin Pharmacol 12:631636.
  • Grim SA, Ryan M, Miles MV, Tang PH, Strawburg RH, DeGrauw TJ, Fakhoury TA, Baumann RJ. (2003) Correlation of levetiracetam concentrations between serum and saliva. Ther Drug Monit 25:6166.
  • Grimsley SR, Jann MW, Carter JG, D'Mello AP, D'Souza MJ. (1991) Increased carbamazepine plasma concentrations after fluoxetine coadministration. Clin Pharmacol Ther 50:1015.
  • Grove J, Alken RG, Schechter PJ. (1984) Assay of γ-vinyl-aminobutyric-acid (4-amino-hex-5-enoic acid) in plasma and urine by automated amino acid analysis. J Chromatogr 306:383387.
  • Gur P, Poklis A, Saady J, Costantino A. (1995) Chromatographic procedures for the determination of felbamate in serum. J Anal Toxicol 19:499503.
  • Gurwitz JH, Field TS, Harrold LR, Rothschild J, Debellis K, Seger AC, Cadoret C, Fish LS, Garber L, Kelleher M, Bates DW. (2003) Incidence and preventability of adverse drug events among older persons in the ambulatory setting. J Am Med Assoc 289:11071116.
  • Gustavson LE, Chu S. (1992) High performance liquid chromatographic procedure for the determination of tiagabine concentrations in human plasma using electrochemical detection. J Chromatogr 574:313318.
  • Gustavson LE, Mengel HB. (1995) Pharmacokinetics of tiagabine, a γ-aminobutyric acid-uptake inhibitor, in healthy subjects after single and multiple doses. Epilepsia 36:605611.
  • Gustavson LE, Boellner SW, Granneman GR, Qian JX, Guenther HJ, El-Shourbagy T, Sommerville KW. (1997) A single-dose study to define tiagabine pharmacokinetics in pediatric patients with complex partial seizures. Neurology 48:10321037.
  • Hachad H, Ragueneau-Majlessi I, Levy RH. (2002) New antiepileptic drugs: review on drug interactions. Ther Drug Monit 24:91103.
  • Hadjiloizou SM, Bourgeois BF. (2007) Antiepileptic drug treatment in children. Expert Rev Neurother 7:179193.
  • Haegele KD, Schechter PJ. (1986) Kinetics of the enantiomers of vigabatrin after an oral dose of the racemate or the active S-enantiomer. Clin Pharmacol Ther 4:581586.
  • Hamilton RA, Garnett WR, Kline BJ, Pellock JM. (1981) Effects of food on valproic acid absorption. Am J Hosp Pharm 38:14901493.
  • Hammerlein A, Derendorf H, Lowenthal DT. (1998) Pharmacokinetic and pharmacodynamic changes in the elderly. Clinical implications. Clin Pharmacokinet 35:4964.
  • Hanks GW. (1979) Clobazam: pharmacological and therapeutic profile. Br J Clin Pharmacol 7(Suppl. 1):151S155S.
  • Harden CL, Trifiletti R, Kutt H. (1996) Felbamate levels in patients with epilepsy. Epilepsia 37:280283.
  • Heimann G, Gladtke E. (1977) Pharmacokinetics of phenobarbital in childhood. Eur J Clin Pharmacol 12:305310.
  • Hengy H, Kolle EU. (1985) Determination of gabapentin in plasma and urine by high performance liquid chromatography and precolumn labeling for ultraviolet detection. J Chromatogr 341:473478.
  • Henriksen O, Johannessen SI. (1982) Clinical and pharmacokinetic observations on sodium valproate – a 5-year follow-up study in 100 children with epilepsy. Acta Neurol Scand 65:504523.
  • Hirsch LJ, Weintraub D, Du Y, Buchsbaum R, Spencer HT, Hager M, Straka T, Bazil CW, Adams DJ, Resor SR Jr, Morrell MJ. (2004) Correlating lamotrigine serum concentrations with tolerability in patients with epilepsy. Neurology 63:10221026.
  • Hirsch LJ, Arif H, Buchsbaum R, Weintraub D, Lee J, Chang JT, Resor SR Jr, Bazil CW. (2007) Effect of age and comedication on levetiracetam pharmacokinetics and tolerability. Epilepsia 48:13511359.
  • Holland ML, Uetz JA, Kung TNG. (1988) Automated capillary gas chromatographic assay using flame ionization detection for the determination of topiramate in plasma. J Chromatogr 433:276281.
  • Hooper WD, Bochner F, Eadie MJ, Tyrer JH. (1974) Plasma protein binding of diphenylhydantoin: effects of sex hormones, renal and hepatic diseases. Clin Pharmacol Ther 15:276282.
  • Hooper WE, Kavanagh MC, Dickinson RG. (1990) Determination of gabapentin in plasma and urine by capillary column gas chromatography. J Chromatogr 529:167174.
  • Hoppener RJ, Kuyer A, Meijer JW, Hulsman J. (1980) Correlation between daily fluctuations of carbamazepine serum levels and intermittent side effects. Epilepsia 21:341350.
  • Hosoda N, Miura H, Takanashi S, Shirai H, Sunaoshi W. (1991) The long-term effectiveness of clonazepam therapy in the control of partial seizures in children difficult to control with carbamazepine monotherapy. Jpn J Psychiatry Neurol 45:471473.
  • Houtman PN, Hall SK, Green A, Rylance GW. (1990) Rapid anticonvulsant monitoring in an epilepsy clinic. Arch Dis Child 65:264268.
  • Howard JR, Dix RK, Shumaker RC, Perhach JL. (1992) Effect of felbamate on carbamazepine pharmacokinetics. Epilepsia 33(Suppl. 3):8485.
  • Hussein G, Troupin AS, Montouris G. (1996) Gabapentin interaction with felbamate. Neurology 47:1106.
  • Hussein Z, Posner J. (1997) Population pharmacokinetics of lamotrigine monotherapy in patients with epilepsy: retrospective analysis of routine monitoring data. Br J Clin Pharmacol 43:457464.
  • Ifa DR, Falci M, Moraes ME, Bezerra FA, Moraes MO, De Nucci G. (2001) Gabapentin quantification in human plasma by high-performance liquid chromatography coupled to electrospray tandem mass spectrometry. Application to bioequivalence study. J Mass Spectrom 36:188194.
  • Isoherranen N, Spiegelstein O, Bailer M, Zhang J, Merriweather M, Yagen B, Roeder M, Triplett AA, Schurig V, Finnell RH. (2003) Developmental outcome of levetiracetam, its major metabolite in humans, 2-pyrrolidone N-butyric acid, and its enantiomer (R)-α-ethyl-oxo-pyrrolidine acetamide in a mouse model of teratogenicity. Epilepsia 42:12801288.
  • Ito T, Yamaguchi T, Miyizaki H, Sekine Y, Shimizu M, Ishida S, Yagi K, Kakegawa N, Seino M, Wada T. (1982) Pharmacokinetic studies of AD-810, a new antiepileptic compound. Arzneimittelforschung 32:15811586.
  • Ivanova M, Piunti A, Marziali E, Komarova N, Reggi MA, Kenndler E. (2003) Microemulsion electrokinetic chromatography applied for separation of levetiracetam from other antiepileptic drugs in polypharmacy. Electrophoresis 24:992998.
  • Jalling B. (1974) Plasma and cerebrospinal fluid concentrations of phenobarbital in infants given single doses. Dev Med Child Neurol 16:781793.
  • Jalling B. (1975) Plasma concentrations of phenobarbital in the treatment of seizures in newborns. Acta Paediatr Scand 64:514524.
  • Jannuzzi G, Cian P, Fattore C, Gatti G, Bartoli A, Monaco F, Perucca E. (2000) A multicenter randomized controlled trial on the clinical impact of therapeutic drug monitoring in patients with newly diagnosed epilepsy. Epilepsia 41:222230.
  • Johannessen SI, Morselli PL, Pippenger CE, Richens A, Schmidt D, Meinardi H. (1980) Antiepileptic therapy: advances in drug monitoring. Raven Press, New York .
  • Johannessen SI. (1990) Pharmacokinetics of antiepileptic drugs and their clinical significance. Behav Neurol 3(Suppl. 1):111.
  • Johannessen SI, Battino D, Berry DJ, Bialer M, Kramer G, Tomson T, Patsalos PN. (2003) Therapeutic drug monitoring of the newer antiepileptic drugs. Ther Drug Monit 25:347363.
  • Johannessen SI, Helde G, Brodtkorb E. (2005) Levetiracetam concentrations in serum and breast milk at birth and during lactation. Epilepsia 46:775777.
  • Johannessen SI, Tomson T. (2006) Pharmacokinetic variability of newer antiepileptic drugs: when is monitoring needed? Clin Pharmacokinet 45:10611075.
  • Jung D, Powell JR, Walson P, Perrier D. (1980) Effect of dose on phenytoin absorption. Clin Pharmacol Ther 28:479485.
  • Jürgens U. (1987) Simultaneous determination of zonisamide and nine other anti-epileptic drugs and metabolites in serum. A comparison of microbore and conventional high-performance liquid chromatography. J Chromatogr 385:233240.
  • Kaibe K, Nishimura S, Ishii H, Kalbe K, Nishimura S, Ishii H, Sunahara N, Naruto S, Kurooka S. (1990) Competitive binding enzyme immunoassay for zonisamide, a new antiepileptic drug, with selected paired-enzyme labeled antigen and antibody. Clin Chem 37:2427.
  • Kang H, Leppik IE. (1984) Phenytoin binding in patients undergoing renal transplantation. Neurology 34:8386.
  • Kauffman RE, Habersang R, Lansky L. (1977) Kinetics of primidone metabolism and excretion in children. Clin Pharmacol Ther 22:200205.
  • Kaufman KR, Gerner R. (1998) Lamotrigine toxicity secondary to sertraline. Seizure 7:163165.
  • Kaufman DW, Kelly JP, Rosenberg L, Anderson TE, Mitchell AA. (2002) Recent patterns of medication use in the ambulatory adult population of the United States: the Slone survey. J Am Med Assoc 287:337344.
  • Kay L, Kampmann JP, Svendsen TL, Vergman B, Hansen JE, Skovsted L, Kristensen M. (1985) Influence of rifampicin and isoniazid on the kinetics of phenytoin. Br J Clin Pharmacol 20:323326.
  • Kelley MT, Walson PD, Cox S, Dusci LJ. (1997) Population pharmacokinetics of felbamate in children. Ther Drug Monit 19:2936.
  • Khoo KC, Mendels J, Rothbart M, Garland WA, Colburn WA, Min BH, Lucek R, Carbone JJ, Boxenbaum HG, Kaplan SA. (1980) Influence of phenytoin and phenobarbital on the disposition of a single oral dose of clonazepam. Clin Pharmacol Ther 28:368375.
  • Kilpatrick ES, Forrest G, Brodie MJ. (1996) Concentration-effect and concentration-toxicity relationships with lamotrigine: a prospective study. Epilepsia 37:534538.
  • Knapp J, Boknik P, Gumbinger HG, Linck B, Luss H, Muller FU, Schmitz W, Vahlensieck U, Naumann J. (1999) Quantitation of clobazam in human plasma using high-performance liquid chromatography. J Chromatogr Sci 37:145149.
  • Koerner M, Yerby M, Friel P, McCormick K. (1989) Valproic acid disposition and protein binding in pregnancy. Ther Drug Monit 11:228230.
  • Krämer G, Tettenborn B, Flesh G. (1991) Oxcarbazepine-verapamil drug interaction study in healthy volunteers. Epilepsia 32(Suppl. 1):7071.
  • Kudriakova TB, Sirota LA, Rozova GI, Gorkov VA. (1992) Autoinduction and steady-state pharmacokinetics of carbamazepine and its major metabolites. Br J Clin Pharmacol 33:611615.
  • Kunicki PK. (2001) Simple and sensitive high-performance liquid chromatographic method for the determination of 1,5-benzodiazepine clobazam and it's active metabolite N-desmethyl clobazam in human serum and urine with application to 1,4-benzodiazepines analysis. J Chromatogr B Biomed Sci Appl 750:4149.
  • Kushnir MM, Crossett J, Brown PI, Urry FM. (1999) Analysis of gabapentin in serum and plasma by solid-phase extraction and gas chromatography-mass spectrometry for therapeutic drug monitoring. J Anal Toxicol 23:1236.
  • Kutt H, Winters W, Kokenge R, McDowell F. (1964) Diphenylhydantoin metabolism, blood levels, and toxicity. Arch Neurol 11:642648.
  • Kutt H, McDowell F. (1968) Management of epilepsy with diphenylhydantoin sodium. Dosage regulation for problem patients. J Am Med Assoc 203:969972.
  • Labbate LA, Pollack MH, Otto MW, Tesar GM, Rosenbaum JF. (1994) The relationship of alprazolam and clonazepam dose to steady- state concentration in plasma. J Clin Psychopharmacol 14:274276.
  • Lacroix C, Wojciechowski F, Danger P. (1993) Monitoring of benzodiazepines (clobazam, diazepam and their main active metabolites) in human plasma by column-switching high-performance liquid chromatography. J Chromatogr 617:285290.
  • Lai ML, Huang JD. (1993) Dual effect of valproic acid on the pharmacokinetics of phenytoin. Biopharm Drug Dispos 14:365370.
  • Lambie DG, Johnson RH, Nanda RN, Shakir RA. (1976) Therapeutic and pharmacokinetic effects of increasing phenytoin in chronic epileptics on multiple drug therapy. Lancet 2:386389.
  • Lancas FM, Sozza MA, Queiroz ME. (2003) Simultaneous plasma lamotrigine analysis with carbamazepine, carbamazepine 10,11 epoxide, primidone, phenytoin, phenobarbital, and PEMA by micellar electrokinetic capillary chromatography (MECC). J Anal Toxicol 27:304308.
  • Larkin JG, Herrick AL, McGuire GM, Percy-Robb IW, Brodie MJ. (1991) Antiepileptic drug monitoring at the epilepsy clinic: A prospective evaluation. Epilepsia 32:8995.
  • Lau AH, Gustavson LE, Sperelakis R, Lam NP, El Shourbagy T, Qian JX, Leyden T. (1997) Pharmacokinetics and safety of tiagabine in subjects with various degrees of hepatic function. Epilepsia 38:445451.
  • LeGatt DF, McIntosh DP. (1993) Clobazam and norclobazam quantitation in serum by capillary gas chromatography with electron-capture detection. Clin Biochem 26:159163.
  • Lensmeyer GL, Gidal BE, Wiebe DA. (1997) Optimized high-performance liquid chromatographic determination of lamotrigine in serum with concomitant determination of phenytoin, carbamazepine, and carbamazepine epoxide. Ther Drug Monit 19:292300.
  • Leppik IE, Fisher J, Kriel R, Sawchuk RJ. (1986) Altered phenytoin clearance with febrile illness. Neurology 36:13671370.
  • Leppik IE, Rarick JO, Walczak TS, Tran TA, White JR, Gumnit RJ. (2002) Effective levetiracetam doses and serum concentrations: age effects. Epilepsia 43(Suppl. 7):240.
  • Leppik IE, Rarick JO, White JR, Tran TA, Walczak TS, Gumnit RJ. (2003) Doses and serum concentrations of levetiracetam in the elderly. Epilepsia 44(Suppl. 8):158.
  • Levert H, Odou P, Robert H. (2002) LC determination of oxcarbazepine and its active metabolite in human serum. J Pharm Biomed Anal 15:517525.
  • Levy RH, Cenraud B, Loiseau P, Akbaraly R, Brachet-Liermain A, Guyot M, Gomeni R, Morselli PL. (1980) Meal-dependent absorption of enteric-coated sodium valproate. Epilepsia 21:273280.
  • Levy RH, Loiseau P, Guyot M, Blehaut HM, Tor J, Moreland TA. (1984) Stiripentol kinetics in epilepsy: nonlinearity and interactions. Clin Pharmacol Ther 36:661669.
  • Levy RH, Hachad H, Yao C, Ragueneau-Majlessi I. (2003) Relationship between extent of inhibition and inhibitor dose: literature evaluation based on the metabolism and transport drug interaction database. Curr Drug Metab 4:371380.
  • Lhatoo S, Wong ICK, Sander JWAS. (2000) Prognostic factors affecting long-term retention of topiramate in patients with chronic epilepsy. Epilepsia 41:338341.
  • Lillisunde P, Seppala T. (1990) Simultaneous screening and quantitative analysis of benzodiazepines by dual-channel gas chromatography using electron-capture and nitrogen-phosphorus detection. J Chromatogr 533:97110.
  • Lin MC, Kou HS, Chen CC, Wu SM, Wu HL. (2004) Simple and sensitive fluorimetric liquid chromatography method for the determination of valproic acid in plasma. Channel gas chromatography using electron-capture and nitrogen-phosphorus detection. J Chromatogr B Analyt Technol Biomed Life Sci 810:169172.
  • Lindberger M, Luhr O, Johannessen, SI, Larsson S, Tomson T. (2003) Serum concentrations and effects of gabapentin and vigabatrin: Observations from a dose titration study. Ther Drug Monit 25:378383.
  • Linjakumpu T, Hartikainen S, Klaukka T, Veijola J. (2002) Use of medications and polypharmacy are increasing among the elderly. J Clin Epidemiol 55:809817.
  • Liu H, Delgado MR. (1999) Therapeutic drug concentration monitoring using saliva samples. Focus on anticonvulsants. Clin Pharmacokinet 36:453470.
  • Livingstone S, Bernman W, Pauli L. (1975) Anticonvulsant blood drug levels. Practical applications based on 12 years experience. J Am Med Assoc 232:6062.
  • Lloyd P, Flesch G, Dieterle W. (1994) Clinical pharmacology and pharmacokinetics of oxcarbazepine. Epilepsia 35(Suppl. 3):1013.
  • Lund L. (1974) Anticonvulsant effect of diphenylhydantoin relative to plasma levels. Arch Neurol 31:289294.
  • Lundberg B, Nergardh A, Boreus LO. (1982) Plasma concentrations of valproate during maintenance therapy in epileptic children. J Neurol 228:133141.
  • Maas B, Garnett WR, Pellock JM, Comstock TJ. (1987) A comparative bioavailability study of carbamazepine tablets and a chewable tablet formulation. Ther Drug Monit 9:2833.
  • MacKichan JJ. (1989) Protein binding drug displacement interactions fact or fiction? Clin Pharmacokinet 16:6573.
  • Makino K, Goto Y, Sueyasu M, Futagami K, Kataoka Y, Oishi R. (1997) Micellar electrokinetic capillary chromatography for therapeutic drug monitoring of zonisamide. J Chromatogr B Biomed Sci Appl 695:417425.
  • Malone SA, Eadie MJ, Addison RS, Wright AW, Dickinson RG. (2006) Monitoring salivary concentrations. J Clin Neurosci 13:902907.
  • Masuda Y, Utsui Y, Shiraishi Y, Karasawa T, Yoshida K, Shimuzu M. (1979) Relationship between plasma concentrations of diphenylhydantoin, phenobarbital, carbamazepine and 3-sulfamoylmethyl-1,2-benzisoxazole (AD-810), a new anticonvulsant agent, and their anticonvulsant or neurotoxic effects in experimental animals. Epilepsia 20:623633.
  • Matar KM, Nicholls PJ, Tekle A, Bawazir SA, Al-Hassan MI. (1999) Liquid chromatographic determination of six antiepileptic drugs and two metabolites in microsamples of human plasma. Ther Drug Monit 21:559566.
  • Matsumoto K, Miyazaki H, Fujii T, Hashimoto M. (1989) Binding of sulfonamides to erythrocytes and their components. Chem Pharm Bull (Tokyo) 37:19131915.
  • Mattson RH, Cramer JA. (1980) Valproic acid and ethosuximide interaction. Ann Neurol 7:583584.
  • Mattson RH, Cramer JA, Williamson PD, Novelly RA. (1978) Valproic acid in epilepsy: clinical and pharmacological effects. Ann Neurol 3:2022.
  • Mattson RH, Cramer JA, Collins JF, Smith DB, Delgado-Escueta AV, Browne TR, Williamson PD, Treiman DM, McNamara JO, McCutchen CB. (1985) Comparison of carbamazepine, phenobarbital, phenytoin, and primidone in partial and secondarily generalized tonic-clonic seizures. N Engl J Med 313:145151.
  • May TW, Rambeck B, Jürgens U. (1996a) Serum concentrations of lamotrigine in epileptic patients: the influence of dose and comedication. Ther Drug Monit 18:523531.
  • May TW, Rambeck B, Sälke-Kellermann A. (1996b) Fluctuations of 10-hydroxy-carbazepine during the day in epileptic patients. Acta Neurol Scand 93:393397.
  • May TW, Rambeck B, Jürgens U. (1999) Influence of oxcarbazepine and methsuximide on lamotrigine concentrations in epileptic patients with and without valproic acid comedication: results of a retrospective study. Ther Drug Monit 21:175181.
  • May TW, Rambeck B, Jürgens U. (2002) Serum concentrations of topiramate in patients with epilepsy: influence of dose, age, and comedication. Ther Drug Monit 24:366374.
  • May TW, Korn-Merker E, Rambeck B. (2003) Clinical pharmacokinetics of oxcarbazepine. Clin Pharmacokinet 42:10231042.
  • May TW, Rambeck B, Neb R, Jürgens U. (2007) Sreum concentrations of pregabalin in patients with epilepsy: the influence of dose, age, and comedication. Ther Drug Monit 29:789794.
  • Mazzucchelli I, Onat FY, Ozkara C, Atakli D, Specchio LM, Neve AL, Gatti G, Perucca E. (2006) Changes in the disposition of oxcarbazepine and its metabolites during pregnancy and the puerperium. Epilepsia 47:504509.
  • Mazzucchelli I, Franco V, Fattore C, Marchiselli R, Perucca E, Gatti G. (2007) A novel enantioselective microassay for the high-performance liquid chromatography determination of oxcarbazepine and its active metabolite monohydroxycarbazepine in human plasma. Ther Drug Monit 29:319324.
  • McKee PJW, Larkin JG, Brodie AF, Percy-Robb IW, Brodie MJ. (1993) Five years of anticonvulsant monitoring on site at the epilepsy clinic. Ther Drug Monit 15:8390.
  • McKee PJ, Blacklaw J, Forrest G, Gillham RA, Walker SM, Connelly D, Brodie MJ. (1994) A double-blind, placebo-controlled interaction study between oxcarbazepine and carbamazepine, sodium valproate and phenytoin in epileptic patients. Br J Clin Pharmacol 37:2732.
  • McLean MJ. (1995) Gabapentin. Epilepsia 36(Suppl. 2):S57S86.
  • McNamara PJ, Colburn WA, Gibaldi MJ. (1979) Time course of carbamazepine self-induction. Pharmacokinet Biopharm 7:6368.
  • Mecarelli O, Li Voti P, Pro S, Romolo FS, Rotolo M, Pulitano P, Accornero N, Vanacore N. (2007) Saliva and serum levetiracetam concentrations in patients with epilepsy. Ther Drug Monit 29:313318.
  • Meijer JWA, Meinardi H, Gardner–Thorpe C, Van Der Kleijn E. (1973) Methods of analysis of anti-epileptic drugs. Excerpta Medica, Amsterdam .
  • Mikati MA, Browne TR, Collins JF. (1989) Time course of carbamazepine autoinduction. The VA Cooperative Study No. 118 Group. Neurology 39:592594.
  • Miles MV, Howlett CM, Tennison MB, Greenwood RS, Cross RE. (1989) Determination of N-desmethylmethsuximide serum concentrations using enzyme-multiplied and fluorescence polarization immunoassays. Ther Drug Monit 11:337342.
  • Miles MV, Tang PH, Glauser TA, Ryan MA, Grim SA, Strawburg RH, DeGrauw TJ, Baumann RJ. (2003) Topiramate concentration in saliva: an alternative to serum monitoring. Pediatr Neurol 29:143147.
  • Miles MV, Tang PH, Ryan MA, Grim SA, Fakhoury TA, Strawburg RH, DeGrauw TJ, Baumann RJ. (2004) Feasibility and limitations of oxcarbazepine monitoring using salivary monohydroxy carbamazepine (MHD). Ther Drug Monit 26:300304.
  • Mimaki T, Mino M, Sugimoto T. (1992) Antiepileptic effect and serum levels of zonisamide in epileptic patients with refractory seizures. In SunshineI (Ed) Recent developments in therapeutic drug monitoring and clinical toxicology. Marcel Dekker, New York , pp. 437442.
  • Mimaki T. (1998) Clinical pharmacology and therapeutic drug monitoring of zonisamide. Ther Drug Monit 20:593597.
  • Mimrod D, Specchio LM, Britzi M, Perucca E, Specchio N, La Neve A, Soback S, Levy RH, Gatti G, Doose DR, Maryanoff BE, Bialer M. (2005) A comparative study of the effect of carbamazepine and valproic acid on the pharmacokinetics and metabolic profile of topiramate at steady state in patients with epilepsy. Epilepsia 46:10461054.
  • Mirza Wu, Jafri AH, Ali S. (1999) Role of gabapentin levels in the control of partial seizures. Epilepsia 40(Suppl. 7):145.
  • Miura H, Hosada N, Takanashi S. (1993) Once daily dose of zonisamide monotherapy in the control of partial seizures in children: Clinical effects and their pharmacokinetic basis. Jpn J Ther Drug Monit 10:240241.
  • Monjanel-Mouterde S, Antoni M, Bun H, Botta-Frindlund D, Gauthier A, Durand A, Cano JP. (1994) Pharmacokinetics of a single oral dose of clobazam in patients with liver disease. Pharmacol Toxicol 74:345350.
  • Monks A, Richens A. (1980) Effect of single doses of sodium valproate on serum phenytoin levels and protein binding in epileptic patients. Clin Pharmacol Ther 27:8995.
  • Morris RG, Black AB, Harris AL, Batty AB, Sallustio BC. (1998) Lamotrigine and therapeutic drug monitoring: retrospective survey following the introduction of a routine service. Br J Clin Pharmacol 46:547551.
  • Naito H, Itoh N, Matsui N, Eguchi T. (1988) Monitoring plasma concentrations of zonisamide and clonazepam in an epileptic attempting suicide by overdose of the drugs. Curr Ther Res 43:463467.
  • Neels HM, Sierens AC, Naelaerts K, Sharpé SL, Hatfield GM, Lambert WE. (2004) Therapeutic drug monitoring of old and newer anti-epileptic drugs. Clin Chem Lab Med 42:12281255.
  • Nelson E, Powell JR, Conrad K, Likes K, Byers J, Baker S, Perrier D. (1982) Phenobarbital pharmacokinetics and bioavailability in adults. J Clin Pharmacol 22:141148.
  • Noguchi H, Tomita N, Yoshida K. (1988) Simultaneous HPLC determination of zonisamide and other antiepileptic drugs in human serum. Jpn Pharmacol Ther 16:48054811.
  • Oeltgen PR, Shank WA Jr, Blouin RA, Clark T. (1984) Clinical evaluation of the Abbott TDx fluorescence polarization immunoassay analyzer. Ther Drug Monit 6:360367.
  • Ohman I, Vitols S, Tomson T. (2000) Lamotrigine in pregnancy: pharmacokinetics during delivery, in the neonate, and during lactation. Epilepsia 41:709713.
  • Ohman I, Beck O, Vitils S, Tomson T. (2007) Plasma concentrations of lamotrigine and its 2-N-glucuronide metabolite during pregnancy in women with epilepsy. Epilepsia Epub ahead of print.
  • Pacifici GM, Viani A, Rizzo G, Carrai M, Rane A. (1987) Plasma protein binding of clonazepam in hepatic and renal insufficiency and after hemodialysis. Ther Drug Monit 9:369373.
  • Painter MJ, Pippenger C, MacDonald H, Pitlick W. (1977) Phenobarbital and diphenylhydantoin levels in neonates with seizures. J Pediatr 92:315319.
  • Painter MJ, Pippenger C, Wasterlain C, Barmada M, Pitlick W, Carter G, Aben S. (1981) Phenobarbital and phenytoin in neonatal seizures: metabolism and tissue distribution. Neurology 31:11071112.
  • Patsalos PN, Lascelles PT. (1977) Effect of sodium valproate on plasma protein binding of diphenylhydantoin. J Neurol Neurosurg Psychiatr 40:570574.
  • Patsalos PN, Stephenson TJ, Krishna S, Elyas AA, Lascelles PT, Wiles CM. (1985) Side-effects induced by carbamazepine-10, 11-epoxide. Lancet 11:496.
  • Patsalos PN, Sander JWAS, Oxley JR, Lascelles PT. (1987) Immediate anticonvulsant drug monitoring in the management of epilepsy. Lancet 11:39.
  • Patsalos PN. (1990a) A comparative pharmacokinetic study of conventional and chewable carbamazepine in epileptic patients. Br J Clin Pharmacol 29:574577.
  • Patsalos PN. (1990b) New antiepileptic drugs. Ann Clin Biochem 36:1019.
  • Patsalos PN, Duncan JS. (1995) The pharmacology and pharmacokinetics of vigabatrin. Rev Contemp Pharmacother 6:447456.
  • Patsalos PN. (2000) Pharmacokinetic profile of levetiracetam: toward ideal characteristics. Pharmacol Ther 85:7785.
  • Patsalos PN, Elyas AA, Ratnaraj N, Iley J. (2002) Concentration-dependent displacement of tiagabine by valproic acid. Epilepsia 43(Suppl. 8):143.
  • Patsalos PN, Perucca E. (2003a) Clinically important drug interactions in epilepsy: general features and interactions between antiepileptic drugs. Lancet Neurol 2:347356.
  • Patsalos PN, Perucca E. (2003b) Clinically important drug interactions in epilepsy: interactions between antiepileptic drugs and other drugs. Lancet Neurol 2:473481.
  • Patsalos PN. (2004a) Clinical pharmacokinetics of levetiracetam. Clin Pharmacokinet 43:707724.
  • Patsalos PN. (2004b) Levetiracetam: pharmacology and therapeutics in the treatment of epilepsy and other neurological conditions. Rev Contemp Pharmacother 13:1168.
  • Patsalos PN. (2005) Anti-epileptic drug interactions. A clinical guide. Clarius Press, Guildford .
  • Patsalos PN, Ghattaura S, Ratnaraj N, Sander JW. (2006) In situ metabolism of levetiracetam in blood of patients with epilepsy. Epilepsia 47:18181821.
  • Pellock JM. (1999) Felbamate in epilepsy therapy: evaluating the risks. Drug Saf 3:225239.
  • Pellock JM, Glauser TA, Bebin EM, Fountain NB, Ritter FJ, Coupez RM, Shields WD. (2001) Pharmacokinetic study of levetiracetam in children. Epilepsia 42:15741579.
  • Pennell PB. (2003) Antiepileptic drug pharmacokinetics during pregnancy and lactation. Neurology 61(Suppl.2):S35S42.
  • Pennell PB, Newport DJ, Stowe ZN, Helmers SL, Montgomery JQ, Henry TR. (2004) The impact of pregnancy and childbirth on the metabolism of lamotrigine. Neurology 62:292295.
  • Pennell PB, Peng L, Newport DJ, Ritchie JC, Koganti A, Holley DK, Newman M, Stowe ZN. (2007) Lamotrigine in pregnancy. Clearance, therapeutic drug monitoring, and seizure frequency. Neurology 2007 [Epub ahead of print].
  • Penovich PE, Schroeder M, Gates JR, Morriarty GL. (1997) Clinical experience with topiramate: correlation of serum levels with efficacy and adverse effects. Epilepsia 38(Suppl. 8):181.
  • Perucca E. (1980). Plasma protein binding of phenytoin in health and disease: relevance to therapeutic drug monitoring. Ther Drug Monit 2:331344.
  • Perucca E, Richens A. (1981) Antiepileptic drugs: clinical aspects. In RichensA, MarksV. (Eds), Therapeutic drug monitoring. Churchill Livingstone, Edinburgh , pp. 320348.
  • Perucca E, Ruprah M, Richens A. (1981) Altered drug binding to serum proteins in pregnant women: therapeutic relevance. J R Soc Med 74:422426.
  • Perucca E. (1984) Free level monitoring of antiepileptic drugs. Clinical usefulness and case studies. Clin Pharmacokinet 9(Suppl. 1):7178.
  • Perucca E, Grimaldi R, Gatti G, Pirracchio S, Crema F, Frigo GM. (1984a) Pharmacokinetics of valproic acid in the elderly. Br J Clin Pharmacol 17:665669.
  • Perucca E, Hedges A, Makki KA, Ruprah M, Wilson JF, Richens A. (1984b) A comparative study of the relative enzyme-inducing properties of anticonvulsant drugs in epileptic patients. Br J Clin Pharmacol 18:401410.
  • Perucca E, Grimaldi R, Crema A. (1985) Interpretation of drug levels in acute and chronic disease states. Clin Pharmacokinet 10:498513.
  • Perucca E. (1987) Drug metabolism in pregnancy, infancy and childhood. Pharmacol Ther 34:129143.
  • Perucca E, Bialer M. (1996) The clinical pharmacokinetics of the newer antiepileptic drugs. Focus on topiramate, zonisamide and tiagabine. Clin Pharmacokinet 31:2946.
  • Perucca E, Gram L, Avanzini G, Dulac O. (1998) Antiepileptic drugs as a cause of worsening of seizures. Epilepsia 39:517.
  • Perucca E. (1999) The clinical pharmacokinetics of the new antiepileptic drugs. Epilepsia 40(Suppl. 9):S7S13.
  • Perucca E. (2000) Is there a role for therapeutic drug monitoring of new anticonvulsants? Clin Pharmacokinet 38:191204.
  • Perucca E, Dulac O, Shorvon S, Tomson T. (2001) Harnessing the clinical potential of antiepileptic drug therapy: dosage optimization. CNS Drugs 15:609621.
  • Perucca E. (2002a) Pharmacological and therapeutic properties of valproate. A summary after 35 years of clinical experience. CNS Drugs 16:695714.
  • Perucca E. (2002b). Overtreatment in epilepsy: adverse consequences and mechanisms. Epilepsy Res 52:2533.
  • Perucca E, Gidal BE, Baltes E. (2003) Effects of antiepileptic comedication on levetiracetam pharmacokinetics: a pooled analysis of data from randomized adjunctive therapy trials. Epilepsy Res 53:4756.
  • Perucca E. (2005) An introduction to antiepileptic drugs. Epilepsia 46(Suppl. 4):3137.
  • Perucca E. (2006). Clinical pharmacokinetics of new generation antiepileptic drugs at the extremes of age. Clin Pharmacokinet 45:351363.
  • Perucca E, Berlowitz D, Birnbaum A, Cloyd JC, Garrard J, Hanlon JT, Levy RH, Pugh MJ. (2006a) Pharmacological and clinical aspects of antiepileptic drugs use in the elderly. Epilepsy Res 68(Suppl. 1):S49S63.
  • Perucca E, Albani F, Capovilla G, Bernardina BD, Michelucci R, Zaccara G. (2006b) Recommendations of the Italian League against Epilepsy working group on generic products of antiepileptic drugs. Epilepsia 47(Suppl 5):1620.
  • Perucca E, Cloyd J, Critchley D, Fuseau E. (2008) Rufinamide: Clinical pharmacokinetics and concentration-response relationships in patients with epilepsy. Epilepsia. (In press).
  • Petters I, Peng DR, Rane A. (1984) Quantitation of clonazepam and its 7-amino and 7-acetamido metabolites in plasma by high-performance liquid chromatography. J Chromatogr 306:241248.
  • Pippenger CE, Penry JK, Kutt H. (1978) Antiepileptic drugs: quantitative analysis and interpretation. Raven Press, New York .
  • Pisani F, Narbone M, Trunfio C, Fazio A, La Rosa G, Oteri G, Di Perri R. (1984) Valproic acid-ethosuximide interaction: a pharmacokinetic study. Epilepsia 25:229233.
  • Pisani F, Caputo M, Fazio A, Oteri G, Russo M, Spina E, Perucca E, Bertilsson L. (1990) Interaction of carbamazepine-10,11-epoxide, an active metabolite of carbamazepine, with valproate: a pharmacokinetic study. Epilepsia 31:339342.
  • Pisani F, Fazio A, Oteri G, Artesi C, Xiao B, Perucca E, Di Perri R. (1994) Effects of the antidepressant drug viloxazine on oxcarbazepine and its hydroxylated metabolites in patients with epilepsy. Acta Neurol Scand 90:130132.
  • Pitlick W, Painter M, Pippenger C. (1978) Phenobarbital pharmacokinetics in neonates. Clin Pharmacol Ther 23:346350.
  • Pokrajac M, Miljkovic B, Spiridonovic D, Varagic VM. (1992) An improved gas chromatographic determination of valproic acid and valpromide in plasma. Pharma Acta Helvetica 67:237240.
  • Pucci V, Bugamelli F, Mandrioli R, Ferranti A, Kenndler E, Raggi MA. (2004) High-performance liquid chromatographic determination of levetiracetam in human plasma: comparison of different sample clean-up procedures. Biomed Chromatogr 18:3744.
  • Pugh CB. (1987) Phenytoin and phenobarbital protein binding alternations in a uremic burn patient. Drug Intell Clin Pharm 21:264267.
  • Pullar T, Kumar S, Chrystyn H, Rice P, Peaker S, Feely MT. (1991) The prediction of steady-state plasma phenobarbitone concentrations (following low-dose phenobarbitone) to refine its use as an indicator of compliance. Br J Clin Pharmacol 32:329333.
  • Queiroz ME, Silva SM, Carvalho D, Lancas FM. (2002) Determination of lamotrigine simultaneously with carbamazepine, carbamazepine epoxide, phenytoin, phenobarbital, and primidone in human plasma by SPME-GC-TSD. J Chromatogr Sci 40:219223.
  • Ragueneau-Majlessi I, Bajpai M, Levy RH. (2002) Phenytoin and other hydantoins-iteractons with other drugs. In LevyRH, MattsonRH, MeldrumBS, PeruccaE (Eds) Antiepileptic Drugs 5th ed. Lippincott Williams & Wilkins, Philadelphia , pp. 581590.
  • Rambeck B, Wolf P. (1993) Lamotrigine clinical pharmacokinetics. Clin Pharmacokinet 25:433443.
  • Ramsay RE, Rowan AJ, Slater JD, Collins J, Nemire R, Ortiz WR, and the VA Cooperative Study Group. (1994) Effect of age on epilepsy and its treatment: results of the VA Cooperative Study. Epilepsia 35(Suppl. 8):9.
  • Ramsay RE, Rowan AJ, Pryor FM. (2004) Special considerations in treating the elderly patient with epilepsy. Neurology 62(Suppl. 2):S24S29.
  • Randinitis EJ, Posvar EL, Alvey CW, Sedman AJ, Cook JA, Bockbrader HN. (2003) Pharmacokinetics of pregabalin in subjects with various degrees of renal function. J Clin Pharmacol 43:277283.
  • Ratnaraj N, Goldberg VD, Hjelm M. (1990) Temperature effects on the estimation of free levels of phenytoin, carbamazepine and phenobarbitone. Ther Drug Monit 12:465472.
  • Ratnaraj N, Doheny HC, Patsalos PN. (1996) A micromethod for the determination of the new antiepileptic drug levetiracetam (UCB L059) in serum or plasma by high performance liquid chromatography. Ther Drug Monit 18:154157.
  • Ratnaraj N, Patsalos PN. (1998) A high performance liquid chromatography micromethod for the simultaneous determination of vigabatrin and gabapentin in serum. Ther Drug Monit 20:430434.
  • Reife RA, Pledger G, Doose D, Lim P, Ward C. (1995) Topiramate PK/PD analysis. Epilepsia 36(Suppl. 3):S152.
  • Retzow A, Vens-Cappell B, Wangemann M. (1997) Influence of food on the pharmacokinetics of a new multiple unit sustained release sodium valproate formulation. Arzneimitteelforschung 47:13471350.
  • Rey E, Pons G, Richard MO, Vauzelle F, D'Athis P, Chiron C, Dulac O, Beaumont D, Olive G. (1990) Pharmacokinetics of the individual enantiomers of vigabatrin (gamma-vinyl-GABA) in epileptic children. Br J Clin Pharmacol 30:253257.
  • Rey E, Pons G, Olive G. (1992) Vigabatrin. Clinical pharmacokinetics. Clin Pharmacokinet 23:267278.
  • Richens A. (1979) Clinical pharmacokinetics of phenytoin. Clin Pharmacokinet 4:153169.
  • Richens A. (1993) Clinical pharmacokinetics of gabapentin. In ChadwickD. (Ed) New trends in epilepsy management: the role of gabapentin. Royal Society of Medicine Services, London , pp. 4146.
  • Richens A. (1995) Quality control of drug estimates. Acta Neurol Scand Suppl. 60:8184.
  • Riffitts JM, Gisclon LG, Stubbs RJ, Palmer ME. (1999) A capillary gas chromatographic assay with nitrogen phosphorus detection for the quantification of topiramate in human plasma, urine and whole blood. J Pharm Biomed Anal 19:363371.
  • Riva R, Albani F, Contin M, Baruzzi A. (1996) Pharmacokinetic interactions between antiepileptic drugs. Clinical considerations. Clin Pharmacokinet 31:470493.
  • Romanyshyn LA, Wichmann JK, Kucharczyk N, Shumaker RC, Ward D, Sofia RD. (1994) The simultaneous determination of felbamate, primidone, phenobarbital, carbamazepine, two carbamazepine metabolites, phenytoin, and one phenytoin metabolite in human plasma by high performance liquid chromatography. Ther Drug Monit 16:9096.
  • Rosenfeld WE, Liao S, Kramer LD, Anderson G, Palmer M, Levy RH, Nayak RK. (1997) Comparison of the steady-state pharmacokinetics of topiramate and valproate in patients with epilepsy during monotherapy and concomitant therapy. Epilepsia 38:324333.
  • Rosenfeld WE, Doose DR, Walker SA, Badassarre JS, Reife RA. (1999) A study of topiramate pharmacokinetics and tolerability in children with epilepsy. Pediatr Neurol 20:339344.
  • Rouan MC, Lecaillon JB, Godbillon J, Menard F, Darragon T, Meyer P, Kourilsky O, Hillion D, Aldigier JC, Jungers P. (1994) The effect of renal impairment on the pharmacokinetics of oxcarbazepine and its metabolites. Eur J Clin Pharmacol 47:161167.
  • Rouan MC, Souppart C, Alif L, Moes D, Lecaillon JB, Godbillon J. (1995) Automated analysis of a novel anti-epileptic compound, CGP 33,101, and its metabolite, CGP 47,292, in body fluids by high-performance liquid chromatography and liquid-solid extraction. J Chromatogr B Biomed Appl 667:307313.
  • Rowan AJ, Ramsay RE, Collins JF, Pryor F, Boardman KD, Uthman BM, Spitz M, Frederick T, Towne A, Carter GS, Marks W, Felicetta J, Tomyanovich ML; VA Cooperative Study 428 Group. (2005) New onset geriatric epilepsy: a randomized study of gabapentin, lamotrigine, and carbamazepine. Neurology 64:18681873.
  • Rupp W, Badian M, Christ O, Hajdu P, Kulkarri RD, Tauber K, Uihlein M, Bender R, Vanderbeke O. (1979) Pharmacokinetics of single and multiple doses of clobazam in humans. Br J Clin Pharmacol 7(Suppl. 1):51S57S.
  • Ryan MA, Grim SA, Miles MV, Tang PH, Fakhoury TA, Strawburg RH, DeGrauw TJ, Baumann RJ. (2003a) Correlation of lamotrigine concentrations between serum and saliva. Pharmacotherapy 23:15501557.
  • Ryan M, Miles MV, Tang PH, Strawburg RH, DeGrauw TJ, Fakhoury TA, Baumann RJ. (2003b) Correlation of levetiracetam concentrations between serum and saliva. Ther Drug Monit 25:6166.
  • Sabers A, Ôhman I, Christensen J, Tomson T. (2003) Oral contraceptives reduce lamotrigine plasma levels. Neurology 61:570571.
  • Sachdeo RC, Kramer LD, Rosenberg A, Sachdeo S. (1992) Felbamate monotherapy: controlled trial in patients with partial onset seizures. Ann Neurol 32:386392.
  • Sachdeo RC, Narang-Sachdeo SK, Howard JR, Dix RK, Shumaker RC, Perhach JL, Rosenberg A. (1993) Steady-state pharmacokinetics and dose-proportionality of felbamate after oral administration of 1200, 2400, and 3600 mg/day of felbamate. Epilepsia 34(Suppl. 6):80.
  • Sachdeo RC, Sachdeo SK, Walker SA, Kramer LD, Nayak RK, Doose DR. (1996) Steady-state pharmacokinetics of topiramate and carbamazepine in patients with epilepsy during monotherapy and concomitant therapy. Epilepsia 37:774780.
  • Saetre E, Perucca E, Isojarvi J, Gjerstad L; LAM 40089 Study Group. (2007) An international multicenter randomized double-blind controlled trial of lamotrigine and sustained-release carbamazepine in the treatment of newly diagnosed epilepsy in the elderly. Epilepsia 48:129302.
  • Salem SA, Rajjayabun P, Shepherd AM, Stevenson IH. (1978) Reduced induction of drug metabolism in the elderly. Age Ageing 7:6873.
  • Sallustio BC, Kassapidis C, Morris RG. (1994) High Performance liquid chromatography determination of clonazepam in plasma using solid-phase extraction. Ther Drug Monit 16:174178.
  • Sandor P, Sellers EM, Dumbrell M, Khouw V. (1981) Effect of short- and long-term alcohol use on phenytoin kinetics in chronic alcoholics. Clin Pharmacol Ther 30:390397.
  • Sawchuk RJ, Pepin SM, Leppik IE, Gumnit RJ. (1982) Rapid and slow release phenytoin in epileptic patients at steady state: comparative plasma levels and toxicity. J Pharmacokinet Biopharm 10:365382.
  • Schechter PJ. (1989) Clinical pharmacology of vigabatrin. Br J Clin Pharmacol 27:19S22S.
  • Schmidt D, Haenel F. (1984) Therapeutic plasma levels of phenytoin, phenobarbital, and carbamazepine: individual variation in relation to seizure frequency and type. Neurology 34:12521255.
  • Schmidt D, Einicke I, Haenel FT. (1986) The influence of seizure type on the efficacy of plasma concentrations of phenytoin, phenobarbital, and carbamazepine. Arch Neurol 43:263265.
  • Schneider H, Janz D, Gardner–Thorpe C, Meinardi H, Sherwin AL. (1975) Clinical pharmacology of anti-epileptic drugs. Springer–Verlag, Berlin .
  • Schramm TM, McKinnon GE, Eadie MJ. (1993) Gas chromatographic assay of vigabatrin enantiomers in plasma. J Chromatogr 616:3944.
  • Schultz H, Feldman K, Faigle JW, Kriemler HP, Winkler T. (1986) The metabolism of 14C-oxcarbazepine in man. Xenobiotica 16:769778.
  • Sennoune S, Mesdjian E, Bonneton J, Genton P, Dravet C, Roger J. (1992) Interactions between clobazam and standard antiepileptic drugs in patients with epilepsy. Ther Drug Monit 14:269274.
  • Sghendo L, Mifsud J, Ellul-Micallef R, Portelli J, Millership JS. (2002) A sensitive gas chromatographic/mass spectrometric method for the resolution and quantification of ethosuximide enantiomers in biological fluids. J Chromatogr B Analyt Technol Biomed Life Sci 772:307315.
  • Sherwin A, Robb P, Lechter M. (1973) Improved control of epilepsy by monitoring plasma ethosuximide. Arch Neurol 28:178181.
  • Shihabi ZK, Oles K, Hinsdale M. (2003) Analysis of the antiepileptic drug Keppra by capillary electrophoresis. J Chromatogr A 1004:912.
  • Shimoyama R, Ohkubo T, Sugawara K. (1999) Monitoring zonisamide in human breast milk and maternal plasma by solid-phase extraction HPLC method. Biomed Chromatogr 13:370372.
  • Shorvon SD, Chadwick D, Galbraith AW, Reynolds EH. (1978) One drug for epilepsy. Br Med J 1:474476.
  • Shorvon SD, Reynolds EH. (1979) Reduction in polypharmacy for epilepsy. Br Med J 2:10231025.
  • Shorvon SD, Galbraith AW, Laundy M, Vydelingum L, Reynolds EH. (1980) Monotherapy for epilepsy. In JohannessenSI, MorselliPL, PippengerCE, RichensA, SchmidtD, MeinardiH (Eds) Antiepileptic therapy: Advances in drug monitoring. Raven press, New York , pp. 213219.
  • Shumaker RC, Fantel C, Kelton E, Wong K, Weliky I. (1990) Evaluation of the elimination of (14C) felbamate in healthy men. Epilepsia 31:642.
  • Siddiqui A, Kerb R, Weale ME, Brinkmann U, Smith A, Goldstein DB, Wood NW, Sisodiya SM. (2003) Association of multidrug resistance in epilepsy with a polymorphism in the drug-transporter gene ABCB1. N Engl J Med 348:14421448.
  • Sidhu J, Job S, Singh S, Philipson R. (2006) The pharmacokinetic and pharmacodynamic consequences of the co-administration of lamotrigine and a combined oral contraceptive in healthy female subjects. Br J Clin Pharmacol 61:191199.
  • Sivenius J, Kälviäinen R, Ylinen A, Riekkinen P. (1991) A double-blind study of gabapentin in the treatment of partial seizures. Epilepsia 32:539542.
  • So EL, Wolff D, Graves NM, Leppik IE, Cadcino GD, Pixton GC, Gustavson LE. (1995) Pharmacokinetics of tiagabine as add-on therapy in patients taking enzyme-inducing antiepilepsy drugs. Epilepsy Res 22:221226.
  • Song D, Zhang S, Kohlhof K. (1996) Quantitative determination of clonazepam in plasma by gas chromatography-negative ion chemical ionization mass spectrometry. J Chromatogr B Biomed Appl 686:199204.
  • Specht U, Elsner H, May TW, Schimichowski B, Thorbecke R. (2003) Postictal serum levels of antiepileptic drugs for detection of noncompliance. Epilepsy Behav 4:487495.
  • Speed DJ, Dickson SJ, Cairns ER, Kim ND. (2000) Analysis of six anticonvulsant drugs using solid phase extraction, deuterated internal standards, and gas chromatographic-mass spectrometry. J Anal Toxicol 24:685690.
  • Spina E, Martines C, Fazio A, Trio R, Pisani F, Tomson T. (1991) Effect of phenobarbital on the pharmacokinetics of carbamazepine-10,11- epoxide, an active metabolite of carbamazepine. Ther Drug Monit 13:109112.
  • Stephen LJ, Sills GJ, Brodie MJ. (2000) Topiramate in refractory epilepsy: a prospective observational study. Epilepsia 41:977980.
  • Stewart BH, Kugler AR, Thompson PR, Bockbrader HN. (1993) A saturable transport mechanism in the intestinal absorption of gabapentin is the underlying cause of lack of proportionality between increasing dose and drug levels in plasma. Pharm Res 10:276281.
  • Stowe CD, Lee KR, Storgion SA, Phelps SJ. (2000) Altered phenytoin pharmacokinetics in children with severe, acute traumatic brain injury. J Clin Pharmacol 40:14521461.
  • Streete JM, Berry DJ, Newbery JE. (1991) The analysis of clobazam and its metabolite desmethylclobazam by high-performance liquid chromatography. Ther Drug Monit 13:339344.
  • Striano S, Striano P, Di Nocera P, Italiano D, Fasiella C, Ruosi P, Bilo L, Pisani F. (2006) Relationship between serum mono-hydroxy-carbazepine concentrations and adverse effects in patients with epilepsy on high-dose oxcarbazepine therapy. Epilepsy Res 69:170176.
  • Sundqvist A, Tomson T, Lundkvist B. (1997) Pharmacokinetics of valproic acid in patients with juvenile myoclonic epilepsy on monotherapy. Ther Drug Monit 19:153159.
  • Sutton G, Kupferberg HJ. (1975) Isoniazid as an inhibitor of primidone metabolism. Neurology 25:11791181.
  • Tanaka E, Terada M, Misawa S, Wakasugi C. (1996) Simultaneous determination of twelve benzodiazepines in human serum using a new reversed-phase chromatographic column on a 2-microns porous microspherical silica gel. J Chromatogr B Biomed Appl 682:173178.
  • Tanaka E. (1999) Clinically significant pharmacokinetic drug interactions between antiepileptic drugs. J Clin Pharm Ther 24:8792.
  • Tang BK, Yilmaz B, Kalow W. (1984) Determination of phenobarbital, p-hydroxyphenobarbital and phenobarbital-N-glucoside in urine by gas chromatography chemical ionization mass spectrometry. Biomed Mass Spectrom 11:462465.
  • Tang PH, Miles MV, Glauser TA, Coletta L, Doughman N, Doose D, Frey M, De Grauw A. (2000) An improved gas chromatography assay for topiramate monitoring in pediatric patients. Ther Drug Monit 22:195201.
  • Taylor C, McLean J, Bockbrader H. (1986) Zonisamide. In MeldrumBS, PorterR. (Eds) New anticonvulsant drugs. John Libby, London , pp. 277294.
  • The Felbamate Study Group in Lennox-Gastaut Syndrome. (1993) Efficacy of felbamate in childhood epileptic encephalopathy (Lennox-Gastaut syndrome). N Engl J Med 328:2933.
  • Theis JG, Koren G, Daneman R, Sherwin AL, Menzano E, Cortez M, Hwang P. (1997) Interactions of clobazam with conventional antiepileptics in children. J Child Neurol 12:208213.
  • Theis JG, Sidhu J, Palmer J, Job S, Bullman J, Ascher J. (2005) Lack of pharmacokinetic interaction between oxcarbazepine and lamotrigine. Neuropsychopharmacology 30:22692274.
  • Thompson CD, Barthen MT, Hopper DW, Miller TA, Quigg M, Hudspeth C, Montouris G, Marsh L, Perhach JL, Sofia RD, Macdonald TL. (1999) Quantification in patient urine samples of felbamate and three metabolites: acid carbamate and two mercapturic acids. Epilepsia 40:769776.
  • Tompson DJ, Ali I, Oliver-Willwong R, Job S, Zhu L, Lemme F, Hammer AE, Vuong A, Messenheimer JA. (2007) Steady-state pharmacokinetics of lamotrigine when converting from a twice-daily immediate-release to a once-daily extended-release formulation in subjects with epilepsy (The COMPASS Study). Epilepsia [Epub ahead of print.
  • Tomson T, Lindbom U, Ekqvist B, Sundqvist A. (1994) Epilepsy and pregnancy: a prospective study of seizure control in relation to free and total plasma concentrations of carbamazepine and phenytoin. Epilepsia 35:122130.
  • Tomson T, Öhman I, Vitols S. (1997) Lamotrigine in pregnancy and lactation: a case report. Epilepsia 38:10391041.
  • Tomson T, Johannessen SI. (2000) Therapeutic monitoring of the new antiepileptic drugs. Eur J Clin Pharmacol 55:697705.
  • Tomson T, Luef G, Sabers A, Pittschieler S, Öhman I. (2006) Valproate effects on kinetics of lamotrigine in pregnancy and treatment with oral contraceptives. Neurology 67:12971299.
  • Tomson T, Dahl M, Kimland E. (2007a) Therapeutic monitoring of antiepileptic drugs for epilepsy. Cochrane Database Syst Rev 1:CD002216.
  • Tomson T, Palm R, Kallen K, Ben-Menachem E, Soderfeldt B, Danielsson B, Johansson R, Luef G, Öhman I. (2007b) Pharmacokinetics of levetiracetam during pregnancy, delivery, in the neonatal period, and lactation. Epilepsia 48:11111116.
  • Tran TA, Leppik IE, Blesi K, Sathanandan ST, Remmel R. (2002) Lamotrigine clearance during pregnancy. Neurology 59:251255.
  • Turnbull DM, Howel D, Rawlins MD, Chadwick DW. (1985) Which drug for the adult epileptic patient: phenytoin or valproate? Br Med J 290:815819.
  • Twyman RE, Ben-Menachem E, Veloso F, Banhof MAM, Wu SC. (1999) Plasma topiramate (TPM) concentration vs. therapeutic response during monotherapy. Epilepsia 40(Suppl. 7):111112.
  • Uthman BM, Rowan J, Ahmann PA, Leppik IE, Schachter SC, Sommerville KW, Shu V. (1998) Tiagabine for complex partial seizures. A randomized, add-on, dose-response trial. Arch Neurol 55:5662.
  • Van Heiningen PN, Eve MD, Oosterhuis B, Jonkman JH, De Bruin H, Hulsman JA, Richens A, Jensen PK. (1991) The influence of age on the pharmacokinetics of the antiepileptic agent oxcarbazepine. Clin Pharmacol Ther 50:410441.
  • Van Parys JAP, Meinardi H. (1994) Survey of 260 patients treated with oxcarbazepine (Trileptal) on a named-patient basis. Epilepsy Res 84:224227.
  • Van Wieringen A, Vrijlandt C. (1983) Ethosuximide intoxication caused by interaction with isoniazid. Neurology 33:12271228.
  • Vauzelle-Kervroedan F, Rey E, Cieuta C, Pariente-Khayat A, Pons G, D'Athis P, Bidault R, Dulac O, Olive G. (1996) Influence of concurrent antiepileptic medication on the pharmacokinetics of lamotrigine as add-on therapy in epileptic children. Br J Clin Pharmacol 41:325330.
  • Vermeij TAC, Edelbroek RM. (1994) High-performance liquid chromatographic and megabore gas-liquid chromatographic determination of levetiracetam (ucb L059) in human serum after solid-phase extraction. J Chromatogr Biomed Appl 662:134139.
  • Vermeij TAC, Edelbroek RM. (1998) High-performance liquid chromatographic analysis of vigabatrin enantiomers in human serum by precolumn derivatization with o-phthaldialdehyde-N-acetyl-L-cysteine and fluorescence detection. J Chromatogr B Biomed Sci Appl 716:233238.
  • Vermeij TA, Edelbroek PM. (2004) Simultaneous high-performance liquid chromatographic analysis of pregabalin, gabapentin and vigabatrin in human serum by precolumn derivatization with 0-phthadialdehyde and fluorescence detection. J Chromatogr B Analyt Technol Biomed Life Sci 810:297303.
  • Vestal RE, Norris AH, Tobin JD, Cohen BH, Shock NW, Andres R. (1975) Antipyrine metabolism in man: influence of age, alcohol, caffeine, and smoking. Clin Pharmacol Ther 18:425432.
  • Viswanathan CT, Booker HE, Welling PG. (1978) Bioavailability of oral and intramuscular phenobarbital. J Clin Pharmacol 18:100105.
  • Vollmer KO, Von Hodenberg A, Kölle EU. (1988) Pharmacokinetics and metabolism of gabapentin in rat, dog and man. Arzneim Forsch Drug Res 36:830839.
  • Volosov A, Xiaodong, Perucca E, Yagen B, Sintov A, Bialer M. (1999) Enantioselective pharmacokinetics of 10-hydroxycarbazepine after oral administration of oxcarbazepine to healthy Chinese subjects. Clin Pharmacol Ther 66:547553.
  • Volosov A, Bialer M, Xiaodong S, Perucca E, Sintov A, Yagen B. (2000) Simultaneous stereoselective high-performance liquid chromatographic determination of 10-hydroxycarbazepine and its metabolite carbamazepine-10,11-trans-dihydrodiol in human urine. J Chromatogr B Biomed Sci Appl 738:419425.
  • Volz M, Christ O, Kellner HM, Kuch H, Fehlhaber HW, Gantz D, Hajdu P, Cavagna F. (1979) Kinetics and metabolism of clobazam in animals and man. Br J Clin Pharmacol 7(Suppl. 1):41S50S.
  • Von Unruh GE, Paar WD. (1985) Gas chromatographic assay for oxcarbazepine and its main metabolites in plasma. J Chromatogr 345:6776.
  • Wad N, Krämer G. (1998) Sensitive high-performance liquid chromatographic method with fluorometric detection for the simultaneous determination of gabapentin and vigabatrin in serum and urine. J Chromatogr B Biomed Sci Appl 701:154158.
  • Wagner ML, Graves NM, Marineau K, Holmes GB, Remmel RP, Leppik IE. (1991) Discontinuation of phenytoin and carbamazepine in patients receiving felbamate. Epilepsia 32:398406.
  • Wall MS, Cox M, Voors J, Ouyang A, Arabshahi L. (2006) A new QMS lamotrigine assay on the Hitachi 917 system. Poster presented at the 60th Annual Meeting of the American Epilepsy Society, San Diego , CA .
  • Walson PD. (1994) Role of therapeutic drug monitoring (TDM) in pediatric anti-convulsant drug dosing. Brain Dev 16:2326.
  • Walson PD, Edge JH. (1996) Clonazepam disposition in paediatric patients. Ther Drug Monit 18:15.
  • Wang X, Patsalos PN. (2002) The pharmacokinetic profile of tiagabine. Rev Contemp Pharmacother 12:225233.
  • Ward DL, Shumaker RC. (1990) Comparative bioavailability of felbamate in healthy men. Epilepsia 31:642.
  • Ward DL, Wagner ML, Perhach JL, Kramer L, Graves N, Leppik I, Shumaker RC. (1991) Felbamate steady-state pharmacokinetics during co-administration of valproate. Epilepsia 32(Suppl. 3):8.
  • Wellington K, Goa KL. (2001) Oxcarbazepine-an update of its efficacy in the management of epilepsy. CNS Drugs 15:137163.
  • Wesseling H, Mols-Thurkow I. (1975) Interaction of diphenylhydantoin (DPH) and tolbutamide in man. Eur J Clin Pharmacol 8:7578.
  • Whyte MP, Dekaban AS. (1977) Metabolic fate of phenobarbital. A quantitative study of p-hydroxyphenobarbital elimination in man. Drug Metab Dispos 5:6370.
  • Wilder BJ, Leppik I, Hietpas TJ, Cloyd JC, Randinitis EJ, Cook J. (2001) Effect of food on absorption of Dilantin Kapseals and Mylan extended phenytoin sodium capsules. Neurology 57:582589.
  • Wilensky AJ, Friel PN, Levy RH, Comfort CP, Kaluzny SP. (1982) Kinetics of phenobarbital in normal subjects and epileptic patients. EurJ Clin Pharmacol 23:8792.
  • Wilensky AJ, Friel PN, Ojemann LM, Kupferberg HJ, Levy RH. (1985) Pharmacokinetics of W-554 (ADD 03055) in epileptic patients. Epilepsia 26:602606.
  • Williams J, Bialer M, Johannessen SI, Krämer G, Levy R, Mattson RH, Perucca E, Patsalos PN. (2003) Interlaboratory variability in the quantification of new generation antiepileptic drugs based on external quality assessment data. Epilepsia 44:4045.
  • Wilson JF, Tsanaclis LM, Williams J, Tedstone JE, Richens A. (1989) Evaluation of assay techniques for the measurement of antiepileptic drugs in serum: a study based on external quality assurance measurements. Ther Drug Monit 11:185195.
  • Wilson JF, Tsanaclis LM, Perrett JE, Williams J, Wicks JFC, Richens A. (1992) Performance of techniques for measurement of therapeutic drugs in serum. A comparison based on external quality assessment data. Ther Drug Monit 14:98106.
  • Wilson EA, Sills GJ, Forrest G, Brodie MJ. (1998) High dose gabapentin in refractory partial epilepsy: clinical observations in 50 patients. Epilepsy Res 29:161166.
  • Woo E, Chan YM, Yu YL, Chan YW, Huang CY. (1988) If a well-stabilized epileptic patient has a subtherapeutic antiepileptic drug level, should the dose be increased? A randomized prospective study. Epilepsia 29:129139.
  • Woodbury DM, Penry JK, Schmidt RP. (1972) Antiepileptic drugs. Raven Press, New York .
  • Wylie E, Pippenger CD, Rothner AD. (1987) Increased seizure frequency with generic primidone. J Am Med Assoc 258:12161217.
  • Yerby MS. Friel PN. McCormick K. (1992) Antiepileptic drug disposition during pregnancy. Neurology 42(Suppl. 5):1216.
  • Zavadil P, Gallagher BB. (1976) Metabolism and excretion of 14C-primidone in epileptic patients. In JanzD. (Ed) Epileptology. Georg Thieme, Stuttgart , pp. 129138.
  • Zhao S, Zhang R, Wang H, Tang L, Pan Y. (2006) Capillary electrophoresis enantioselective separation of vigabatrin enantiomers by precolumn derivatization with dehydroabietylisothiocyante and UV-vis detection. J Chromatogr B Analyt Technol Biom Life Sci 833:186190.